Antibody-Mediated Rejection in Kidney Transplant Recipients

Anonymous. (2009). Annual Report of the US Organ Procurement andTransplantation Network and the Science Registry of Transplant Recipients:Transplantation data 1999-2008. Department of health and human services, Rockville, MD.Search in Google Scholar

Anonymous. (2010). Eurotransplant International Foundation. Annual report 2010. Osterlee, A., Ramel, A. Central Office. Leiden. The Netherlands.Search in Google Scholar

Archdeacon, P., Chan, M., Neuland, C., Velidedeoglu, E., Meyer, J., Tracy, L., Cavaille-Coll, M., Bala, S., Hemandez, A., Albrecht, R. (2011). Summary of FDA Antibody-Mediated Rejection Workshop. Amer. J. Transplant., 11, 896-906.10.1111/j.1600-6143.2011.03525.x21521465Search in Google Scholar

Bartel, G., Wahrmann, M., Regel, H. (2010). Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation. Amer. J. Transplant., 10, 2033-2041.10.1111/j.1600-6143.2010.03226.x20883537Search in Google Scholar

Billen, E., Christiaans, M., van denBerg-Loonen, E. (2009). Clinical relevance of Luminex donor-specific crossmatches: Data from 165 renal transplants. Tiss. Antigens, 74 (3), 205-211.10.1111/j.1399-0039.2009.01283.x19497037Search in Google Scholar

Bruce, V., Suranyi, M. (1995). Understanding rejection. In: The Handbook ofTransplant Immunology. Wood, K. (ed.) MedSci, Oxford, pp. 113-133.Search in Google Scholar

Burns, J., Cornell, L., Perry, D., Pollinger, H., Gloor, J. (2008). Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Amer. J. Transplant., 8, 2684-2694.10.1111/j.1600-6143.2008.02441.x18976305Search in Google Scholar

Cecka, J. (2011). Current methodologies for detection sensitization to HLA antigens. Curr. Opin. Organ Transplant., 16, 398-411.10.1097/MOT.0b013e328348980a21666477Search in Google Scholar

Chapmen, J., Taylor, C., Ting, A., Morris, P. (1986). Hypereacute rejection of renal allograft in the presence of anti-HLA Cw5 antibody. Transplantation, 42, 91-95.10.1097/00007890-198607000-00022Search in Google Scholar

Claas, F., Rahmel, A., Doxiadis, I. (2009). Enhanced kidney allocation to highly sentized patients by the acceptable mismatch program. Transplantation, 88, 447-45310.1097/TP.0b013e3181b04a5f19696624Search in Google Scholar

Clatworthy, M. R. (2011). Targeting B cells and antibody in transplantation. Amer. J. Transplant., 11, 1359-1367.10.1111/j.1600-6143.2011.03554.x414861821668625Search in Google Scholar

Collins, A., Scheeberger, E., Pascual, M. (1999). Compliment activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries. J. Amer. Soc, Nephol., 10, 2208-2215.10.1681/ASN.V1010220810505698Search in Google Scholar

Colvin, R. (2007). Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J. Amer. Soc. Nephrol., 18, 1046-1056.10.1681/ASN.200701007317360947Search in Google Scholar

Danovitch, G. (ed.). (2010). Handbook of Kidney Transplantation. Philadelphia: Wolter Kluwer. 471 pp.Search in Google Scholar

Dragun, D., Muller, D., Brasen, M. (2005). Angiotensin II Type I-receptor activating antibodies in renal allograft rejection. New Engl. J. Med., 352, 558-569.10.1056/NEJMoa03571715703421Search in Google Scholar

Einecke, G., Sis, B., Reeve, J., Mengel, M., Husain, S. (2009). Antibody- mediated microcirculation injury is the major cause of late kidney transplant failure. Amer. J. Transplant., 9, 2520-2509.10.1111/j.1600-6143.2009.02799.x19843030Search in Google Scholar

Everly, M., Terasaki, P., Trivedt, H. (2012). Durability of antibody removal following proteasome inhibitor-based therapy. Transplantation, 93, 572-577.10.1097/TP.0b013e31824612df22262128Search in Google Scholar

Fehr, T., Gaspert, A. (2012). Antibody-mediated kidney allograft rejection: Therapeutic options and their experimental rationale. Transplant. Int., 25, 623-632.10.1111/j.1432-2277.2012.01453.x22394269Search in Google Scholar

Feucht, H, Schneeberger, H, Hillebrand, G. (1993). Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int., 43, 1333-1341.10.1038/ki.1993.1878315947Search in Google Scholar

Fuggle, S., Martin, S. (2008). Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation, 86, 384-389.10.1097/TP.0b013e31817c90f518698240Search in Google Scholar

Gaston, R., Cecka, J., Kasiske, B. (2010). Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation, 90, 68-7610.1097/TP.0b013e3181e065de20463643Search in Google Scholar

Gebel, H., Bray, R. (2000). Sensitization and sensitivity: Defining the unsensitized patient. Transplantation, 69, 1370-1374.10.1097/00007890-200004150-0002710798756Search in Google Scholar

Gloor, J., Sethi, S., Stegall, M., Cosio, F., Rea, D. (2007). Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Amer. J. Transplant., 7, 2124-2130.10.1111/j.1600-6143.2007.01895.x17608832Search in Google Scholar

Halloran, P., de Freitas, D., Einecke, G., Solez, K., Ritchie, A. (2010). An integrated view of molecular changes, histopathology and outcomes in kidney transplant Amer. J. Transplant., 10, 2223-2230.Search in Google Scholar

Halloran, P., Wadgymar, A., Ritchie, S., Falk, J., Solez, K., Srinivasa, N. (1990). The significance of anti-class I antibody response. I. Clinical and pathologic features of anti-class I- mediated rejection. Transplantation, 49, 85-89.10.1097/00007890-199001000-000192301035Search in Google Scholar

Hricik, D. (ed.). (2011). Primer of Transplantation. Willey-Blackwell, UK. 307 pp.10.1002/9781444391770Search in Google Scholar

Kamar, N., Milioto, O., Puissant-Librano, B., Esposito, L., Pierre, M. C., Mohamed, A. O., Lavayssière, L., Cointault, O., Ribes, D., Cardeau, I., Nogier, M. B., Durand, D., Abbal, M., Blancher, A., Rostaing, L. (2010). Incidence and predictive factors for infections disease after rituximab therapy in kidney-transplant patients. Amer. J. Transplant., 10, 89-98.10.1111/j.1600-6143.2009.02785.x19656128Search in Google Scholar

Lefaucheur, C., Suberbielle-Boissel, C., Hill, G. (2009). Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib. Nephrol., 162, 1-11.Search in Google Scholar

Lefaucheur, C., Loupy, A., Hill, G. (2010). Preexisiting donor-specific HLA antibodies predict outcome in kidney transplantation. J. Amer. Soc. Nephrol., 21, 1398-1407.10.1681/ASN.2009101065293859620634297Search in Google Scholar

Lefaucheur, C., Antonie, C., Suberbielle, C., Glotz, D. (2011). Mastering the risk of HLA antibodies in kidney transplantation: An algorithm based on pretransplant single-antigen flow bead techniques. Amer. J. Transplant., 11, 1592-1598.10.1111/j.1600-6143.2011.03560.x21668626Search in Google Scholar

Loupy, A., Suberbielle-Boissel, C., Hill, G., Nochy, D. (2009). Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Amer. J. Transplant., 9, 2561-2570.10.1111/j.1600-6143.2009.02813.x19775320Search in Google Scholar

Loupy, A., Hill, G., Suberbielle, C. (2011). Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with performed donor-specific antibodies (DSA). Amer. J. Transplant., 11, 56-67.10.1111/j.1600-6143.2010.03364.x21199348Search in Google Scholar

Mao, Q., Terasaki, P., Cai, J. (2007). Extremely high association between appearance of HLA antobodies and failure of kidney graft in a five-year longitudinal study. Amer. J. Transplant., 7, 864-875.10.1111/j.1600-6143.2006.01711.x17391129Search in Google Scholar

Marrari, M., Duquesnoy, R. (2010). Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant. Transplant. Immunol., 22, 105-111.10.1016/j.trim.2009.12.00520035868Search in Google Scholar

McDonald, S., Russ, G., Campbell, S., Chadban, S. (2007). Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcome. Amer. J. Transplant., 7, 1201-1208.10.1111/j.1600-6143.2007.01759.x17359502Search in Google Scholar

Mengel, M., Sis, B., Haas, M., Colvin, R., Halloran, P., Racusen, L. (2012). Banff 2011 meeting report: New concepts in antibody-mediated rejection. Amer. J. Transplant., 12, 563-570.10.1111/j.1600-6143.2011.03926.x372865122300494Search in Google Scholar

Mengel, M., Husain, S., Hidalgo, L., Sis, B. (2012). Phenotypes of antibody- mediated rejection in organ transplant. Transplant. Int., 25, 611-622.10.1111/j.1432-2277.2012.01484.x22533649Search in Google Scholar

Montgomery, R. (2010). Renal transplantation across HLA and ABO antibody barriers: Integrating paired donation into desensitization protocols. Amer. J. Transplant., 10, 449-458.10.1111/j.1600-6143.2009.03001.x20121749Search in Google Scholar

Morath, C., Opelz, G., Zeier, M., Susal, C. (2012). Prevention of antibody- mediated kidney transplant rejection. Transplant. Int., 25, 633-645.10.1111/j.1432-2277.2012.01490.x22587522Search in Google Scholar

Muthukumar, T., Mueller, F., Anglicheau, D., Sharma, V., Ding, R., Suthanthiran, M. (2011). Intragraft microRNA expression signatures of interstitial fibrosis and tubular athrophy of human renal allograft. Amer. J. Transplant., 10, 291-298.Search in Google Scholar

Navkivel, B., Alexander, S. (2010). Mechanisms of disease: Rejection of kidney allograft. New Engl. J. Med., 363, 1451-1461.10.1056/NEJMra090292720925547Search in Google Scholar

Poduval, R., Kadambi, P., Josephson, M., Cohn, R., Harald, R. (2005). Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation, 79, 228-235.10.1097/01.TP.0000148987.13199.10Search in Google Scholar

Roelen, D., Doxiadis, I., Claas, F. (2012). Detection and clinical relevance of donor specific HLA antibodies: A matter of debate. Transplant. Int., 25, 604-610.10.1111/j.1432-2277.2012.01491.x22587521Search in Google Scholar

Schnaidt, M., Weinstock, C., Jurisic, M., Schmidt-Horch, B., Ender, A, Wernet, D. (2011). HLA antibody specification using single-antigen beads-a technical solution for the prozone effect. Transplantation, 92, 510-515.10.1097/TP.0b013e31822872dd21869744Search in Google Scholar

Sellares, J., de Frietas, D., Mengel, M., Reeve, J., Matas, A., Halloran, P. (2012). Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Amer. J. Transplant., 12, 388-399.10.1111/j.1600-6143.2011.03840.x22081892Search in Google Scholar

Shehata, N., Palda, V., Meyer, R. (2010). The use of immunoglobulin therapy for patients undergoing solid organ transplantation: An evidence-based practice guideline. Transfuse Med. Rev., 24 (suppl.1) S7.10.1016/j.tmrv.2009.09.01019962580Search in Google Scholar

Sis, B., Jhangri, G., Riopel, J., Chang, D., de Freitas, D. G., Hidalgo, L., Mengel, M., Matas, A., Halloran, P. F. (2012). A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplant. Amer. J. Transplant., 12, 1168-1179.10.1111/j.1600-6143.2011.03931.x22300601Search in Google Scholar

Stegall, M., Gloor, J., Winters, J., Moore, S., Degoey, S. (2006). A comparison of plasmapheresis versus high dose IVIG desensitization in renal allograft recipients with high levels of donor-specific alloantibody. Amer. J. Transplant., 6, 346-353.10.1111/j.1600-6143.2005.01178.x16426319Search in Google Scholar

Stegall, M., Dean, P., Gloor, J. (2009). Mechanisms of alloantibody production to sensitized renal allograft recipients. Amer. J. Transplant., 9, 998-1006.10.1111/j.1600-6143.2009.02612.x19422329Search in Google Scholar

Susal, C., Dohler, B., Opelz, G. (2009). Presensitized kidney graft recipient with HLA class I and II antibodies are at increased risk for graft failure: A collaborative transplant study report. Hum. Immunol., 70, 59-67.10.1016/j.humimm.2009.04.01319375472Search in Google Scholar

Terasaki, P. (2003). Humoral theory of transplantation. Amer. J. Transplant., 3, 665-673.10.1034/j.1600-6143.2003.00135.x12780557Search in Google Scholar

Tripkov, K., Cambell, P., Pazderka, F., Cocfield, S., Solez, K., Halloran, P. (1996). Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Transplantation, 61, 1586-1591.10.1097/00007890-199606150-000078669102Search in Google Scholar

Vaidya, S., Partlow, D., Susskind, B., Noor, M., Barnes, T., Gugliuzza, K. (2006). Prediction of cross-match outcome in highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation, 82, 1524-1532.10.1097/01.tp.0000246311.43634.0a17164726Search in Google Scholar

Venetz, J., Pascual, M. (2007). New treatments for acute humoral rejection in kidney allograft. Expert Opin. Investing. Drugs., 16, 625-632.10.1517/13543784.16.5.62517461736Search in Google Scholar

Wiebe, C., Gibson, I., Blydt-Hansen, T., Karpinski, M., Ho, J. (2012). Evolution and clinical pathologic correlation of de novo donor-specific HLA antibody post kidney transplant. Amer. J. Transplant., 12, 1157-1167.10.1111/j.1600-6143.2012.04013.x22429309Search in Google Scholar

Zachary, A., Montgomery, R., Ratner, L., Racusen, L. (2003). Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation, 76, 1519-1525.10.1097/01.TP.0000090868.88895.E014657698Search in Google Scholar

Zachary, A., Lucas, D., Detrick, B., Leffel, M. (2009). Naturally occurring interference in Luminex assay for HLA-specific antibodies: Characteristics and resolution. Hum, Immunol., 70, 496-502.10.1016/j.humimm.2009.04.00119364516Search in Google Scholar

Zeevi, A., Girnita, A., Duquesnoy, R. (2006). HLA antibody analysis: Sensitivity, specificity, and clinical significance in solid organ transplantation. Immunol. Res., 36, 255-264.10.1385/IR:36:1:255Search in Google Scholar

Zou, Y., Stasny, P., Susal, C., Dohler, B., Opelz, G. (2007). Antibodies against MICA antigens and kidney transplant rejection. New Engl. J. Med.,357, 1293-3000.10.1056/NEJMoa067160Search in Google Scholar